title: Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
authors.forename: B
authors.initials: B
authors.lastname: Roche
authors.forename: S
authors.initials: S
authors.lastname: Rozenberg
authors.forename: E
authors.initials: E
authors.lastname: Cambau
authors.forename: N
authors.initials: N
authors.lastname: Desplaces
authors.forename: E
authors.initials: E
authors.lastname: Dion
authors.forename: G
authors.initials: G
authors.lastname: Dubourg
authors.forename: A C
authors.initials: AC
authors.lastname: Koeger
authors.forename: H
authors.initials: H
authors.lastname: Robin
authors.forename: H
authors.initials: H
authors.lastname: Vergeron
authors.forename: P
authors.initials: P
authors.lastname: Bourgeois
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D015299:Discitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification*; D015363:Quinolones / Q000627:therapeutic use*; D012447:Sacrum
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D017291:Clarithromycin; C061363:sparfloxacin